Literature DB >> 9682009

Co-infusion with a TrkB-Fc receptor body carrier enhances BDNF distribution in the adult rat brain.

S D Croll1, C R Chesnutt, J S Rudge, A Acheson, T E Ryan, J A Siuciak, P S DiStefano, S J Wiegand, R M Lindsay.   

Abstract

Fusion proteins comprising the Fc domain of human IgG and extracellular domains of receptor tyrosine kinases can neutralize the activity of their cognate ligands when administered in molar excess. We have generated a fusion protein using the ectodomain of TrkB (TrkB-Fc). Although the ability of TrkB-Fc to neutralize the activity of brain-derived neurotrophic factor (BDNF) in vitro has been demonstrated, there have been no conclusive demonstrations of its ability to neutralize the activity of BDNF in vivo. We co-infused TrkB-Fc with BDNF into the cortex and hippocampus of adult rats to determine whether TrkB-Fc would interfere with the ability of BDNF to upregulate neuropeptide Y (NPY). We report here that rather than neutralizing the activity of exogenous BDNF, co-infusion with the TrkB-Fc fusion protein greatly increased the volume of tissue in which neuropeptide Y immunostaining was upregulated. In addition, TrkB-Fc greatly enhanced BDNF's distribution through adult brain parenchyma. TrkB-Fc also markedly increased the otherwise limited diffusion of BDNF into brain parenchyma following intraventricular infusion. These results show that rather than neutralizing or sequestering BDNF, the TrkB-Fc, at close to molar equivalence to BDNF, can function as a carrier for BDNF and thus enhance the delivery or penetration of this polypeptide into the brain. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9682009     DOI: 10.1006/exnr.1998.6836

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  10 in total

1.  Biochemical and biophysical investigation of the brain-derived neurotrophic factor mimetic 7,8-dihydroxyflavone in the binding and activation of the TrkB receptor.

Authors:  Xia Liu; Obiamaka Obianyo; Chi Bun Chan; Junjian Huang; Shenghui Xue; Jenny J Yang; Fanxing Zeng; Mark Goodman; Keqiang Ye
Journal:  J Biol Chem       Date:  2014-08-20       Impact factor: 5.157

2.  Hydrogel-delivered brain-derived neurotrophic factor promotes tissue repair and recovery after stroke.

Authors:  Douglas J Cook; Cynthia Nguyen; Hyun N Chun; Irene L Llorente; Abraham S Chiu; Michal Machnicki; Thomas I Zarembinski; S Thomas Carmichael
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

3.  Failure of brain-derived neurotrophic factor-dependent neuron survival in mouse trisomy 16.

Authors:  Susan G Dorsey; Linda L Bambrick; Rita J Balice-Gordon; Bruce K Krueger
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

4.  Exercise decreases myelin-associated glycoprotein expression in the spinal cord and positively modulates neuronal growth.

Authors:  Cristina A Ghiani; Zhe Ying; Jean de Vellis; Fernando Gomez-Pinilla
Journal:  Glia       Date:  2007-07       Impact factor: 7.452

5.  Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function.

Authors:  Abigail Mariga; Jiri Zavadil; Stephen D Ginsberg; Moses V Chao
Journal:  Dev Neurobiol       Date:  2014-08-25       Impact factor: 3.964

6.  Fully human agonist antibodies to TrkB using autocrine cell-based selection from a combinatorial antibody library.

Authors:  Spyros Merkouris; Yves-Alain Barde; Kate E Binley; Nicholas D Allen; Alexey V Stepanov; Nicholas C Wu; Geramie Grande; Chih-Wei Lin; Meng Li; Xinsheng Nan; Pedro Chacon-Fernandez; Peter S DiStefano; Ronald M Lindsay; Richard A Lerner; Jia Xie
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-09       Impact factor: 11.205

7.  Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease.

Authors:  Shudan Wang; Hongyang Yao; Yihua Xu; Rui Hao; Wen Zhang; Hang Liu; Ying Huang; Wei Guo; Bai Lu
Journal:  Theranostics       Date:  2020-05-23       Impact factor: 11.556

Review 8.  Interplay of BDNF and GDNF in the Mature Spinal Somatosensory System and Its Potential Therapeutic Relevance.

Authors:  Francesco Ferrini; Chiara Salio; Elena M Boggio; Adalberto Merighi
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

9.  A Single Domain Shark Antibody Targeting the Transferrin Receptor 1 Delivers a TrkB Agonist Antibody to the Brain and Provides Full Neuroprotection in a Mouse Model of Parkinson's Disease.

Authors:  Emily Clarke; Pawel Stocki; Elizabeth H Sinclair; Aziz Gauhar; Edward J R Fletcher; Alicja Krawczun-Rygmaczewska; Susan Duty; Frank S Walsh; Patrick Doherty; Julia Lynn Rutkowski
Journal:  Pharmaceutics       Date:  2022-06-24       Impact factor: 6.525

Review 10.  Brain-Derived Neurotrophic Factor and Its Potential Therapeutic Role in Stroke Comorbidities.

Authors:  Wei Liu; Xiaohui Wang; Margaret O'Connor; Guan Wang; Fang Han
Journal:  Neural Plast       Date:  2020-01-27       Impact factor: 3.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.